A Double Blind Study to Evaluate a Novel Urine Metabolic Test (MyCellHealth) to Determine Possible Abnormal Cell Metabolism in adults 40 - 80 years old

ATH (Australia) Pty Ltd0 个研究点目标入组 100 人开始时间: 2024年8月26日最近更新: 2024年9月2日

适应症

试验速览

暂无简介。

•Cohort One.
•1.Attending one of the Specialist clinics involved in the study.
•2.Male or female aged between 40 and 80 inclusive.
•3.Otherwise healthy and not known to have malignancy or following appropriate testing to have benign disease as adjudicated by the participant’s doctor.
•Cohort Two:
•1.Attending one of the Specialist clinics involved in the study.
•2.Male or female aged between 40 and 80 inclusive.
•3.Known malignancy determined by the participant’s study doctor by way of routine diagnosis including, but not limited to physical examination, biopsy, pathology and/or imaging.

•To be eligible to participate in the study, participants from all cohorts had to meet none of the following:
•1.Terminally ill stage or palliative
•2.Diagnosed with cancer and currently undergoing chemotherapy, radiation or surgery (not including biopsy)
•3.Currently pregnant, menstruating and or breast feeding
•4.Currently taking sulphur containing medications
•5.Diagnosed with lupus
•6.Prone to UTIs or have had a suspected or diagnosed UTI in the past 7 days.

发起方

ATH (Australia) Pty Ltd